Your browser doesn't support javascript.
loading
Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy.
Chauhan, Vikash P; Chen, Ivy X; Tong, Rong; Ng, Mei Rosa; Martin, John D; Naxerova, Kamila; Wu, Michelle W; Huang, Peigen; Boucher, Yves; Kohane, Daniel S; Langer, Robert; Jain, Rakesh K.
Afiliación
  • Chauhan VP; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Chen IX; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Tong R; Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
  • Ng MR; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Martin JD; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Naxerova K; Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
  • Wu MW; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Huang P; Laboratory for Biomaterials and Drug Delivery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Boucher Y; Department of Anesthesiology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Kohane DS; Division of Critical Care Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Langer R; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Jain RK; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
Proc Natl Acad Sci U S A ; 116(22): 10674-10680, 2019 05 28.
Article en En | MEDLINE | ID: mdl-31040208

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antagonistas de Receptores de Angiotensina / Microambiente Tumoral / Inmunoterapia / Neoplasias Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antagonistas de Receptores de Angiotensina / Microambiente Tumoral / Inmunoterapia / Neoplasias Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2019 Tipo del documento: Article